Stockscreener 앱 받기
248.69
0.14%
-0.265
전일 마감가:
$248.95
열려 있는:
$245.97
하루 거래량:
334.91K
Relative Volume:
0.41
시가총액:
$17.88B
수익:
$2.96B
순이익/손실:
$487.70M
주가수익비율:
37.25
EPS:
6.6758
순현금흐름:
$344.00M
1주 성능:
+4.68%
1개월 성능:
-9.77%
6개월 성능:
+3.17%
1년 성능:
-22.68%
1일 변동 폭
$245.97
$251.33
1주일 범위
$228.00
$251.33
52주 변동 폭
$187.43
$325.20
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, RMD, MDLN, ALC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
248.55 | 17.91B | 2.96B | 487.70M | 344.00M | 6.6758 |
|
ISRG
Intuitive Surgical Inc
|
491.42 | 173.36B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
202.35 | 59.78B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
273.11 | 39.57B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
47.20 | 39.36B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ALC
Alcon Inc
|
78.41 | 38.72B | 10.19B | 1.05B | 1.38B | 2.1044 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
Why The Narrative Around West Pharmaceutical Services (WST) Is Shifting After New Valuation Updates - Yahoo Finance
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory - Insider Monkey
West Pharmaceutical Services Unveils “Synchrony S1” Syringe System to Speed Drug Packaging Development - Yahoo Finance
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services Inc (WST) Trading 5.8% Higher on Fe - GuruFocus
West Pharmaceutical Services stock: Is WST underperforming the healthcare sector? - MSN
WST: Integrated syringe system accelerates development and simplifies compliance for pharma teams - TradingView
West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy? - Finviz
West Pharma Sets February Earnings Reveal as Investors Await 2025 Results - MyChesCo
Selecting A Prefillable Syringe System With Confidence - Bioprocess Online
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Idexx Laboratories (IDXX) and West Pharmaceutical Services (WST) - The Globe and Mail
Most Frequently Asked Questions On The Revised EU GMP Annex 1: Volume 7 - Med Device Online
West Pharmaceutical Services drives innovation in cancer treatment packaging - Traders Union
West Pharmaceutical Services Inc (WST) Shares Up 4.04% on Feb 4 - GuruFocus
Extractables And Leachables Why They're A Critical Part Of Your Contamination Control Strategy Under EU GMP Annex 1 - Pharmaceutical Online
Evercore ISI Lowers Price Target for West Pharmaceutical Services (WST) | WST Stock News - GuruFocus
West Pharmaceutical Services (BIT:1WST) Price Target Decreased by 11.92% to 278.11 - Nasdaq
Truist Financial Corp Has $7.64 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 49.58% Potential Upside - DirectorsTalk Interviews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), West Pharmaceutical Services (WST) and Humana (HUM) - The Globe and Mail
Volume Report: Is West Pharmaceutical Services Inc part of any major index2025 Fundamental Recap & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
New York State Common Retirement Fund Has $23.06 Million Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services (WST) Valuation Check After Recent Share Price Pressure - Yahoo Finance
Published on: 2026-01-31 17:32:53 - Mfd.ru
Assessing West Pharmaceutical Services (WST) After A 32% One-Year Share Price Pullback - Sahm
West Pharmaceutical Services Inc (WST) Shares Gap Down to $225.5 on Jan 30 - GuruFocus
Here's Why West Pharmaceutical (WST) Is a Great 'Buy the Bottom' Stock Now - Zacks Investment Research
Is West Pharmaceutical (WST) Refocusing on Larger-Volume SmartDose a Quiet Shift in Its Strategic Moat? - Sahm
West to Host Fourth-Quarter and Full-Year 2025 Conference Call - BioSpace
Kinston marks anniversary of West Pharmaceutical Services explosion - WCTI
Is West Pharmaceutical Services Inc. a good ESG investmentPortfolio Gains Report & Consistent Return Investment Signals - mfd.ru
West Pharmaceutical Services, Inc. $WST Shares Sold by Bank of New York Mellon Corp - MarketBeat
Process Safety Quiz: Dust Explosions and Fires - ChemistryViews
Prefilled Syringe Barrels Market Set for Dynamic Development - openPR.com
West to sell SmartDose 3.5mL system to AbbVie in $112.5M deal - MSN
West Pharmaceutical Services taps Robert McMahon as CFO - MSN
Ex-Dividend Reminder: West Pharmaceutical Services, Heritage Financial and Entegris - Nasdaq
Assessing West Pharmaceutical (WST) Valuation After Bullish Earnings Outlook And Demand Strength - Sahm
Zacks Research Issues Optimistic Estimate for WST Earnings - MarketBeat
DraftKings, Abbott, And Applovin Are Among Top 10 Large Cap Losers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio? - Benzinga
West to Sell SmartDose 3.5mL System to AbbVie in $112.5M Deal - MyChesCo
Reasons to add West Pharmaceutical stock to your portfolio now - MSN
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MSN
Profit Review: What is Know Labs Incs market positionJuly 2025 Earnings & Weekly High Return Stock Forecasts - baoquankhu1.vn
Is West Pharmaceutical Services Stock Built to Withstand More Downside? - Trefis
West Pharmaceutical Sells SmartDose Rights To AbbVie And Refocuses Portfolio - Sahm
Analysis Recap: Can AROW grow without external funding2025 Breakouts & Breakdowns & Long Hold Capital Preservation Tips - baoquankhu1.vn
WST Launches Synchrony S1 Prefillable Syringe at Pharmapack - sharewise.com
West Pharmaceutical Services Becomes Oversold (WST) - Nasdaq
Bull Run: Is West Pharmaceutical Services Inc trading at a discountM&A Rumor & Weekly Momentum Picks - baoquankhu1.vn
West Pharmaceutical Services (NYSE:WST) Stock Rating Upgraded by Zacks Research - MarketBeat
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
1.32%
자본화:
|
볼륨(24시간):